Rubella virus IVDs

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

buyitnow

PAR PAR (PAR)
01-12-2017

MAH:

R-Biopharm Pty Ltd

class:

Class 3

manufactured_by:

Diesse Diagnostica Senese SPA Strada Dei Laghi 39, Monteriggioni, 53035 Italy

therapeutic_area:

CT771 - Rubella virus IVDs

therapeutic_indication:

Determination of antibodies to rubella virus in human serum.

authorization_status:

A

authorization_date:

2014-04-22